Brief: Nanexa Signs Evaluation Agreement With Pharma Company

Nanexa AB

21/10/2022 09:30

Oct 21 (Reuters) - Nanexa AB  NANEXA.ST :
    * SIGNS EVALUATION AGREEMENT WITH A SPECIALITY PHARMA
COMPANY
    * HAS SIGNED A MATERIAL TRANSFER AND FEASIBILITY STUDY
AGREEMENT
WITH A SPECIALITY PHARMA COMPANY
    * AGREEMENT REGULATES, AMONG OTHER THINGS, DETAILS OF WHAT
SHALL
BE INVESTIGATED, CLARIFICATION REGARDING PATENT RIGHTS,
DETERMINED FEE TO NANEXA FOR THIS EVALUATION

Source text for Eikon:  ID:nMFN4SgvvN 
Further company coverage:  NANEXA.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))